The flagellum expressed by pathogenic microorganisms functions at several stages of infection. In addition to their role in motility, some flagella are attachment organelles, others are used for the secretion of virulence factors, and all are likely to be potent stimuli in triggering the innate immune response and inflammation. The single flagellum of P. aeruginosa serves some of these functions in disease and plays a pivotal role in the formation of bacterial biofilms in nature and possibly in lungs. The long-term goal of this proposal is therefore to understand the biogenesis of this organelle in nature and disease. The major regulatory steps in the flagellar biogenesis have been elucidated but little is known about its regulation in disease. Recent findings demonstrate that growth of P. aeruginosa in respiratory mucus results in a block in flagellin synthesis. The purpose of repression of flagellin synthesis may be to avoid production of potent innate immune response activators and perhaps prevent opsonophagocytosis. The hypothesis that derives from this observation is that down-regulation of flagellin may be a prerequisite for chronic colonization of mucus in Cystic Fibrosis.
The specific aims of this proposal are therefore: 1. Identify the regulatory network which controls flagellin expression and hence flagellum assembly in mucus. 2. Identify the signal for flagellin down-regulation in mucus. 3. Engineer strains of P. aeruginosa that constitutively express a flagellum in mucus and assess their virulence in animal models of infection. The regulatory network that directs the repression of flagellin production within the normal biogenesis pathway will be ascertained by examining the role of an inhibitor of flagellin synthesis, FIgM, in this process if any. The action of novel regulatory mechanisms that may function independent of the flagellar biogenesis pathway will also be examined. The source of the signal in mucus, which controls flagellin expression, will be sought by examining whether adhesion to mucins, or another component of mucus provides these environmental signals. Lastly, P. aeruginosa strains lacking suppression of flagellin synthesis in mucus will be engineered and examined in both an acute and a chronic model of P. aeruginosa lung infection. If flagellin synthesis is deleterious to chronic colonization, this may provide an opportunity for therapeutic intervention, where ectopic expression of flagellin in mucus may be driven to allow host defenses to deal with the organism early in the colonization process.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI045014-06
Application #
6706959
Study Section
Special Emphasis Panel (ZRG1-BM-1 (02))
Program Officer
Taylor, Christopher E,
Project Start
1999-02-01
Project End
2008-02-28
Budget Start
2004-03-01
Budget End
2005-02-28
Support Year
6
Fiscal Year
2004
Total Cost
$290,667
Indirect Cost
Name
University of Florida
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
969663814
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Raoust, Eloise; Balloy, Viviane; Garcia-Verdugo, Ignacio et al. (2009) Pseudomonas aeruginosa LPS or flagellin are sufficient to activate TLR-dependent signaling in murine alveolar macrophages and airway epithelial cells. PLoS One 4:e7259
Ramphal, Reuben; Balloy, Viviane; Jyot, Jeevan et al. (2008) Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin. J Immunol 181:586-92
Balloy, Viviane; Verma, Amrisha; Kuravi, Sudha et al. (2007) The role of flagellin versus motility in acute lung disease caused by Pseudomonas aeruginosa. J Infect Dis 196:289-96
Jyot, Jeevan; Sonawane, Avinash; Wu, Weihui et al. (2007) Genetic mechanisms involved in the repression of flagellar assembly by Pseudomonas aeruginosa in human mucus. Mol Microbiol 63:1026-38
Sonawane, Avinash; Jyot, Jeevan; During, Russell et al. (2006) Neutrophil elastase, an innate immunity effector molecule, represses flagellin transcription in Pseudomonas aeruginosa. Infect Immun 74:6682-9
Ramphal, Reuben; Balloy, Viviane; Huerre, Michel et al. (2005) TLRs 2 and 4 are not involved in hypersusceptibility to acute Pseudomonas aeruginosa lung infections. J Immunol 175:3927-34
Wolfgang, Matthew C; Jyot, Jeevan; Goodman, Andrew L et al. (2004) Pseudomonas aeruginosa regulates flagellin expression as part of a global response to airway fluid from cystic fibrosis patients. Proc Natl Acad Sci U S A 101:6664-8
Dasgupta, Nandini; Wolfgang, Matthew C; Goodman, Andrew L et al. (2003) A four-tiered transcriptional regulatory circuit controls flagellar biogenesis in Pseudomonas aeruginosa. Mol Microbiol 50:809-24
Jyot, Jeevan; Dasgupta, Nandini; Ramphal, Reuben (2002) FleQ, the major flagellar gene regulator in Pseudomonas aeruginosa, binds to enhancer sites located either upstream or atypically downstream of the RpoN binding site. J Bacteriol 184:5251-60
Dasgupta, Nandini; Ferrell, Evan P; Kanack, Kristen J et al. (2002) fleQ, the gene encoding the major flagellar regulator of Pseudomonas aeruginosa, is sigma70 dependent and is downregulated by Vfr, a homolog of Escherichia coli cyclic AMP receptor protein. J Bacteriol 184:5240-50

Showing the most recent 10 out of 15 publications